Building a "One Foundation, Two Wings, Three Domains" Strategy Towards 2030
BioAsia leverages "one foundation" as the root of innovation - a world-leading BAB microbial strain bank that continuously injects fresh momentum into industrial innovation. On this basis, "two technology wings" drive in synergy: synthetic biology reshapes the underlying logic of life, while our proprietary liquid-solid bio-fermentation technology opens up the path from laboratory inspiration to industrial-scale production, turning cutting-edge innovation into industrial reality. Ultimately, this technological momentum is released into "three domains": in precision health, we extend from fungal functional foods to cell-level targeted nutrition and innovative fungal drugs; in bio-agriculture, we leverage microbial technology to promote green agriculture and provide core technologies and raw material support for the entire healthy-agriculture value chain; and in bio-materials, we use PHA and other microbe-based materials to replace petrochemical-based plastics, directly confronting the threat that microplastic particles pose to human health.
With a solid foundation, technology enablement, and deep domain expertise - three elements interlocking - BioAsia is building a complete strategic closed loop covering resources, technology and markets, steadily advancing toward its goal of becoming a global benchmark enterprise in bio-manufacturing. Armed with its proprietary core technology system and full-chain industrialization capabilities, BioAsia is anchoring itself to the national bio-economy strategy, raising China's voice in the global bio-manufacturing competition, and creating a healthier, greener, and safer future for humanity.